Prostate Cancer Clinical Trial
Official title:
UK Genetic Prostate Cancer Study
RATIONALE: Studying samples of blood and tumor tissue from patients with cancer in the
laboratory may help doctors learn more about changes that occur in DNA and identify genes
related to cancer.
PURPOSE: This clinical trial is studying blood and tumor samples from men with an inherited
risk of prostate cancer.
OBJECTIVES:
- To find genes that predispose to prostate cancer (using genetic linkage and other
molecular biology techniques).
- To determine if genes that predispose to prostate cancer are associated with disease
and treatment parameters.
- To determine if genes that predispose to prostate cancer are associated with
environmental factors.
- To estimate the percentage of prostate cancer patients who have a positive family
history of the disease.
- To estimate the relative risk of developing prostate cancer in a currently unaffected
member of a prostate cancer family.
- To ascertain whether relatives of prostate cancer patients are at increased risk of
developing cancers other than prostate cancer.
- To build up a large blood and tumor (both fresh and preserved) bank from patients with
prostate cancer to identify prostate cancer predisposition gene(s), determine the
prevalence and penetrance of prostate cancer predisposition genes in prostate cancer
patients, correlate changes in prostate cancer predisposition gene(s) with disease and
treatment parameters by matching with clinical data from clinical databases already
held as part of the medical record on these patients, and correlate changes in prostate
cancer predisposition gene(s) with environmental factors collected by questionnaire
from these patients.
- To use the blood and tumor bank for marker studies (DNA, RNA, serum, plasma, protein,
and other molecules) to define the role of these markers in disease prediction and
progression.
- To develop microarrays from prostate cancers to determine their genetic profile and
correlate this with prostate cancer genetic predisposition genes.
- To collect tissue from other unaffected and affected members of the family in cases
where a genetic alteration is found, in order to ascertain whether this alteration is
associated with disease risk.
- To collect tissue samples from unaffected family members who show an interest in taking
part in the study.
OUTLINE: Patients are assessed by a family history and epidemiology questionnaire and
undergo a medical record review.
Patients and relatives with prostate cancer may undergo blood sample collection for genetic
analysis of prostate cancer predisposition genes and measurement of markers of associations
with genetic changes associated with prostate cancer. Blood and tumor samples are stored for
future studies.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05540392 -
An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05613023 -
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
|
Phase 3 | |
| Recruiting |
NCT05156424 -
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer
|
Phase 1/Phase 2 | |
| Completed |
NCT03177759 -
Living With Prostate Cancer (LPC)
|
||
| Completed |
NCT01331083 -
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer
|
Phase 2 | |
| Recruiting |
NCT05540782 -
A Study of Cognitive Health in Survivors of Prostate Cancer
|
||
| Active, not recruiting |
NCT04742361 -
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
|
Phase 3 | |
| Completed |
NCT04400656 -
PROState Pathway Embedded Comparative Trial
|
||
| Completed |
NCT02282644 -
Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry
|
N/A | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06305832 -
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
|
Phase 2 | |
| Recruiting |
NCT05761093 -
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
|
||
| Completed |
NCT04838626 -
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
|
Phase 2/Phase 3 | |
| Recruiting |
NCT03101176 -
Multiparametric Ultrasound Imaging in Prostate Cancer
|
N/A | |
| Completed |
NCT03290417 -
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
|
N/A | |
| Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
| Completed |
NCT01497925 -
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer
|
Phase 1 | |
| Recruiting |
NCT03679819 -
Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
|
||
| Completed |
NCT03554317 -
COMbination of Bipolar Androgen Therapy and Nivolumab
|
Phase 2 | |
| Completed |
NCT03271502 -
Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy
|
N/A |